RE:RE:RE:RE:Pretty disappointing if you ask me.I agree this is how it typically works on the venture. We have seen in past the aftermath with pre and post reactions in share volumes.
However, this is Abbvie, a dead serious public entity, now in the big leagues tickle, and everyone is being told information is kept in a vault, with zero tolerance for these antics, and that confidentiality is absolutely paramaount until at least such time the regulations kick in and disclosure reporting prevails. Abbvie would think nothing of severe consequence here, so on one hand it doesn't benefit our collective need to see this excitement happen, on the other hand, its a relief to see that with respect to working with them, everyone has to be on their best behaviour.
So I guess we wait, and in this case, marketing, business relations, process and practices, reporting etc all follow the lead of this larger company. They bring us up in many aspects, and it will always be on their terms.